These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7244587)

  • 1. [Drug therapy of peripheral arterial occlusive disease].
    Mahler F
    Schweiz Med Wochenschr; 1981 May; 111(18):637-40. PubMed ID: 7244587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A; Rieger H
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S; Bach R; Schieffer H
    Int Angiol; 1992; 11(3):204-10. PubMed ID: 1460355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral blood flow velocity in arterial occlusive disease during i.v. long term therapy with vasoactive agents. Plethysmographic comparative study].
    Heidrich H; Witt D; Witt E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1750-2. PubMed ID: 347800
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guidelines for the evaluation of the therapeutic effects of peripheral vasoactive drugs in arterial occlusive disease].
    Adank K; Barras JP; Biland L; Bollinger A; Galeazzi R; Kämpf R; Mirimanoff P; Schelling JL; Widmer LK
    Vasa; 1981; 10(4):337-41. PubMed ID: 7032111
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methods for studying vasoactive drugs in arteriopathy of the leg and chronic venous insufficiency].
    Franco A; Carpentier P
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():79-82. PubMed ID: 2111691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What is the status of vasoactive drugs? Early stages of arterial occlusive disease in general practice--positive series list, 3].
    Schmidt K
    Fortschr Med; 1995 Apr; 113(12):41-2. PubMed ID: 7789936
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilator drugs in peripheral vascular disease.
    Coffman JD
    Am J Hosp Pharm; 1975 Dec; 32(12):1276-81. PubMed ID: 1108646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peripheral vasodilators: from the hemodynamic effect to clinical benefit].
    Chamontin B; Boccalon H
    Therapie; 1995; 50(2):89-93. PubMed ID: 7631297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poststenotic systolic pressure and blood flow measurements during intra-arterial and vasoactive therapy].
    Doering G; Doering F; Hänsgen K; Podhaisky H; Preuss EG; Seige K
    Z Gesamte Inn Med; 1981 Aug; 36(15):524-7. PubMed ID: 7293286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G
    Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
    Leschke M; Schoebel FC; Strauer BE
    Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects of prostanoid therapy. Preliminary results.
    Castagno PL; Di Molfetta L; Merlo M; Barile G; Violato F; Buzzacchino A; Ponzio F
    Minerva Cardioangiol; 2000; 48(1-2):9-18. PubMed ID: 10829583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)].
    Traumann KJ
    Med Klin; 1976 Mar; 71(11):465-8. PubMed ID: 1263995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

  • 20. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.